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Summary
Background: Disclosure is a key element of the informed consent
process. This study examines and compares the priorities for disclo-
sure of the elements of informed consent between parents of
paediatric research subjects and investigators.
Methods: The study sample comprised 184 parents who had been
approached for permission to allow their child to participate in a
clinical anaesthesia or surgery study. Parents were asked to rank 11
elements of informed consent that they believed were most important
for them to know before allowing their child to participate in a
research study. In addition, 38 investigators were asked to rank, in
order of importance, the same elements that they felt were most
important for parents to know.
Results: The results showed that risk was the most important element
considered by both parents and investigators. However, parents
placed significantly greater importance on knowledge of the potential
benefits to their child (direct) and to other children (indirect)
compared with investigators, and less importance on the details of the
protocol and the element of voluntariness.
Conclusions: These results demonstrated differences in the priorities
for disclosure of the elements of consent between parents and
investigators. As such, they may be important in directing the
investigator to focus on the elements that are most important to
parents and thus maximize their ability to provide truly informed
consent.
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Introduction
The importance of disclosure as a key component of
the informed process promulgated the development
of several standards of disclosure, including ‘the
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reasonable doctor standard’, the ‘hypothetical rea-
sonable person standard’ and the ‘subjective stand-
ard’ (1). As such, all investigators have a duty to
disclose material information regarding studies
involving human subjects. Each disclosure requires
the incorporation of several key informational ele-
ments, including the risk and benefits, the purpose
of the study and a description of what is to be
carried out. Failure to provide complete disclosure
such that the subject cannot make an informed
decision is tantamount to negligence (2).
Although the decision of a subject or their surro-
gate to decline participation in a research study must
be respected, nonresponse or nonparticipation may
introduce a significant selection bias (3). It is there-
fore important to optimize the quality of information
provided to research subjects such that the ethical
and scientific needs of the study are met. This study
was designed to identify the elements of consent that
parents consider most important for them to under-
stand prior to making decisions regarding their
child’s participation in a research study, and to
examine if they differ from the elements considered
most important by research personnel. An under-
standing of these differences may help researchers
focus on the elements of disclosure considered most
important by parents and hence maximize their
ability to make an informed decision.
Methods
The study was approved by the University of
Michigan’s Institutional Review Board. The study
population comprised two groups. Group 1 inclu-
ded consecutive parents/guardians who had been
approached for permission to allow their child to
participate in any one of a number of anaesthesia or
surgery research studies presently in progress at our
institution. Information regarding each study was
presented verbally in addition to the written consent
document. The majority of parents were approached
on the day of their child’s surgery. Regardless of
whether or not the parents had consented to their
child’s participation in one of the studies, they were
invited to participate in this study which required
them simply to rank, in order of importance, 11
elements of consent that they believed they needed
to know before deciding to allow their child to
participate in a research study. These 11 elements
are those typically contained within informed con-
sent documents and included: (i) study purpose; (ii)
protocol (what will be done); (iii) freedom to
withdraw; (iv) risks; (v) benefits to their child (direct
benefits); (vi) benefits to other children (indirect
benefits); (vii) alternative treatments or procedures;
(viii) voluntariness; (ix) duration of participation; (x)
whom to contact with questions/problems; and (xi)
confidentiality.
Subjects were asked to rank each element where
1 ¼ most important and 11 ¼ the least important.
The order in which these elements were presented
was changed during the study to avoid any pat-
terned responses. Demographic information, inclu-
ding age (parent and child), gender, race/ethnic
origin, level of education and income, were also
collected.
Group 2 comprised research personnel, including
principal investigators, research assistants and
research nurses who were actively involved in
recruiting paediatric subjects and obtaining informed
consent for anaesthesia and surgery studies. These
individuals were identified from departmental
anaesthesia and surgery personnel directories. Con-
sistent with group 1, the research personnel were
asked to rank the same 11 elements in the order that
they believed was most important for parents to know
prior to making a decision regarding their child’s
participation in research. Demographic information,
including title, degree, years in clinical research,
gender and race/ethnic origin, was also collected.
Statistical analysis
Continous data were analysed using unpaired
t-tests. Comparison of the rankings of importance
between groups was analysed by the Mann–Whit-
ney U-test. Categorical data were analysed by chi-
square with Fisher’s exact test as appropriate.
P < 0.05 was considered statistically significant.
Results
Rankings were obtained from 184 parents; 147 from
parents who had consented to their child’s partici-
pation in one of the anaesthesia or surgery studies
(consenters) and 37 from those who declined (non-
consenters). In addition, rankings were obtained
from 38 research personnel. The demographics of
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the parents and children are presented in Table 1.
There were no differences between consenters and
nonconsenters with respect to age, race and income
level; however, nonconsenters were significantly
more likely to have education beyond high school
than consenters (P ¼ 0.04). Table 2 describes the
demographics of the research personnel.
The rankings of importance of each of the ele-
ments of consent for consenters and nonconsenters
are shown in Table 3. Although both groups rated
risks as the most important element, consenters
rated the benefits to others as significantly more
important than nonconsenters. Table 4 compares the
priority rankings of each element between parents
and research personnel. Once again, risk was rated
as the most important element by both groups.
However, parents placed greater importance on
knowledge of the benefits to their child and other
children compared with the investigators, and less
importance on the details of the protocol and the
issue of voluntariness. There were no statistical







Parent’s age (year) 35.7 ± 7.6 34.6 ± 6.6 35.5 ± 7.4
Child’s age (year) 6.0 ± 4.6 4.7 ± 3.5 5.8 ± 4.4
Child’s health* 8.3 ± 1.8 8.4 ± 1.9 8.3 ± 1.8
Child’s sex (M/F%) 58.2/41.8 74.3/25.7 61.3/38.7
Race, n (%)
Caucasian 124 (86.7) 31 (88.6) 155 (87.1)
African American 6 (4.2) 2 (5.7) 8 (4.5)
Hispanic 3 (2.1) 0 (0.0) 3 (1.7)
Other 9 (6.3) 2 (5.7) 11 (6.2)
Education level, n (%)
£ High school graduate 42 (28.6)† 3 (8.6) 45 (24.7)
Some college 34 (23.1) 11 (31.4) 45 (24.7)
‡ College graduate 71 (48.3) 21 (60.0) 92 (50.5)
Income level, n (%)
< $0–$29000 31 (23.1) 4 (11.4) 35 (21.5)
$30 000–$69000 53 (39.6) 9 (25.7) 62 (38.0)
> $70000 50 (37.3) 16 (45.7) 66 (40.5)
Prior research subject-child 29 (19.1) 6 (16.2) 35 (18.5)
Prior research subject-parent 39 (25.7) 9 (24.3) 48 (25.4)
Data are expressed as mean ± SD and percentage. *Based on a 0–10 scale where 10 ¼ very healthy.
†P < 0.05 versus nonconsenters.
Table 1
Parent and child demographics
Table 2
Demographics of the research personnel (n = 38)
n (%)
Research personnel
Principal investigators 21 (55.3)
Research assistants 10 (26.3)
Research nurses 3 (7.9)
Undergraduate students 3 (7.9)













Priority rankings between consenters and nonconsenters
Elements of consent Consenters Nonconsenters
Risks 2.4 ± 2.4 (1) 2.0 ± 2.2 (1)
Benefits to child 3.7 ± 2.4 (3) 3.0 ± 1.7 (2)
Protocol/procedures 4.7 ± 2.8 (4) 4.9 ± 2.9 (4.5)
Study purpose 5.0 ± 2.8 (4) 5.5 ± 2.8 (4.5)
Benefits to others 5.2 ± 2.4 (5)* 7.2 ± 2.2 (6.5)
Duration of study 6.6 ± 2.2 (6) 6.9 ± 2.2 (7)
Voluntariness 6.6 ± 2.8 (7)* 5.4 ± 2.8 (5)
Freedom to withdraw 7.0 ± 2.9 (7) 6.9 ± 3.0 (7)
Alternatives 7.3 ± 2.8 (8) 6.6 ± 3.0 (6.5)
Whom to contact 8.3 ± 2.2 (9) 8.4 ± 2.4 (9)
Confidentiality 8.6 ± 2.8 (10) 8.3 ± 2.2 (8)
Data are expressed as mean ± SD (median). *P < 0.05 versus
nonconsenters.
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nel with respect to gender, years in research and title
(faculty investigators versus staff).
Twenty-two percent of the studies presented to the
parents were considered to have a therapeutic intent.
Parents of children recruited into studies with thera-
peutic intent ranked the benefits to their child as
significantly more important [2.6 ± 2.1 (median 2)
versus 3.7 ± 2.2 (median 3) P ¼ 0.016] and the pro-
tocol as less important [5.5 ± 2.9 (median 5) versus
4.3 ± 2.6 (median 4) P ¼ 0.014] compared with those
involved in studies with no therapeutic intent.
Discussion
A recent review of research protocols by the
National Bioethics Advisory Commission (NBAC)
identified several areas of concern regarding the
informed consent process, including potentially
coercive recruitment practices, failure to assess
decision-making capacity and the downplaying of
risks (4). Many of these dubious practices may result
from investigators who feel under pressure (intrinsic
or extrinsic) to expedite subject recruitment.
Although it is every investigator’s goal to maximize
recruitment rates in order to provide a representa-
tive sample of sufficient size to achieve statistical
power, it must be achieved through the design of
ethically sensitive protocols involving complete and
honest disclosure. In order that this can be achieved,
investigators must be sensitive to the elements of
disclosure that are most important to the subject/
surrogate in order for them to make an informed
choice.
It should be noted that participation in more than
one study is not generally advocated by our
Institutional Review Board; however, this caveat
may be waived if the investigators agree that the risk
of an additional study is no more than minimal, that
the subject will not be harmed and that the outcome
of the studies will not be disturbed. Furthermore, in
our study, the parent was the research subject
whereas, in the initial study, the child was the
subject. A second issue regarding consent for this
study is that despite the fact that some parents
declined their child’s participation in one of the
studies, they chose to participate in ours. We believe
that this may have reflected differences in the
parents’ perception of risk between the two studies.
Since the risk of our study was minimal and, in our
experience, parents are extremely altruistic, they
may have chosen our study despite declining their
child’s participation.
This study suggests that there are differences
between parents and investigators regarding the
relative importance of certain disclosed elements.
Although both parents and investigators in our
study considered the risks as the most important
element for disclosure, investigators felt that the
disclosure of benefits (direct and indirect) was of
significantly lower priority than the parents. In a
study by Susman et al. eleven paediatricians ranked
risks, benefits to the subject and procedures as the
three most important elements, and freedom to
withdraw, knowledge of participation and benefit to
others as the three least important (5). These results
are similar to ours and reinforce the disparity
between the relative importance of risk and benefit
(particularly indirect). The discrepancy between risk
and benefit is important since the risk/benefit ratio
is one of the principal measures used by Institutional
Review Boards in their review of study protocols.
The finding that disclosure related to confidentiality
was deemed least important by both parents and
investigators was somewhat surprising given the
importance placed on this element by both Institu-
tional Review Boards and the National Institutes of
Health. However, this finding may be a function of
receiving care at a large academic medical centre
where patients expect some sharing of their medical
information between health care providers and
services and recognize their potential for becoming
a research subject.
Table 4
Priority Rankings between Parents and Investigators [mean ± SD
(median)]
Elements of consent All parents Investigators
Risks 2.3 ± 2.3 (1) 2.6 ± 2.0 (2)
Benefits to child 3.5 ± 2.3 (3)* 6.0 ± 2.8 (6)
Protocol/procedures 4.7 ± 2.8 (4)* 2.8 ± 1.5 (2)
Study purpose 5.1 ± 2.8 (4) 4.1 ± 2.8 (4)
Benefits to others 5.7 ± 2.5 (5)* 8.3 ± 2.1 (9)
Duration of study 6.6 ± 2.2 (7) 7.2 ± 2.4 (8)
Voluntariness 6.3 ± 2.8 (7)* 4.3 ± 2.8 (4)
Freedom to withdraw 6.9 ± 2.9 (7) 6.0 ± 2.4 (6)
Alternatives 7.1 ± 2.8 (8) 6.5 ± 2.8 (6.5)
Whom to contact 8.4 ± 2.3 (9) 8.3 ± 2.7 (9)
Confidentiality 8.6 ± 2.7 (10) 8.2 ± 2.6 (9)
*P < 0.05 versus investigators.
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The results also showed that the consenters
ranked the benefits to others as significantly more
important than nonconsenters which may suggest a
greater degree of altruism among those willing to
have their child participate in a study. However,
there are several other factors that influence parents’
decisions to allow their children to be involved in
research projects, including the perceived import-
ance of the study, the risks and benefits and whether
their child had participated in a previous study (6).
Although many studies do not provide a direct
benefit to the subject, there may be significant
indirect benefits for subsequent patients should a
therapy or intervention prove efficacious. A previ-
ous study from our institution showed that the
risk/benefit was a principal factor influencing
parents’ decisions to allow their children to parti-
cipate in a study (6). Furthermore, the study
showed that the majority of parents approached
for permission to allow their child to participate in
a research study were genuinely altruistic, with a
keen desire to help future children. As such, it may
behove investigators to spend extra time to ensure
that the benefits, both direct and indirect, are given
as much consideration as the risks and that the
parents and child fully understand their signifi-
cance.
Regardless of the priority rankings of each ele-
ment examined in this study, it must be noted that
all elements are considered important and required
for disclosure. Furthermore, it could be argued that,
despite statistically significant differences in the
priority ranking between groups, clinical signifi-
cance is less pronounced. However, this study is
the first to address this issue in a surgical population
of children and provides important information
regarding the relative importance of disclosure
elements in the consent process. As such, it is hoped
that these results will help research personnel to
focus on those elements that are most important to
parents in order to maximize parental understand-
ing, and ensure that the rights of the research subject
are protected.
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